Leitat will participate in Cosmetorium 2026, taking place on 21 and 22 October at La Farga in L’Hospitalet de Llobregat,
Leitat supports the pharmaceutical, biotechnology and MedTech industries throughout the development of chemical, biological and natural compounds in preclinical research,
Leitat will participate in MicroTAS 2026, the international conference on miniaturized systems for chemistry and life sciences, taking place from
On 8-9th September, the partners of the APPEAL project gathered once again for their annual consortium meeting, hosted by PharmAI
Leitat will participate in Biospain 2026, one of Europe’s leading events for the biotechnology industry, taking place from 29 September
Ultrasensitive immunoassay for the early detection of non-small cell lung cancer through biomarkers in tumour-derived extracellular vesicles. Abstact: ONCOSOMIX is
Development of a complex secretome-based biological product for the regeneration of acute muscle injuries Abstract: The HERACLES project aims to
Development of new prevention and diagnostic tools for antibiotic-resistant Klebsiella pneumoniae infections Abstract: The project aims to advance the clinical development
Leitat, Ona Therapeutics and IRB Barcelona Collaborate to Develop a New Therapy for Colorectal Cancer The objective of the ADC-CRC
Recently, the PREDICTFTD consortium gathered in Desenzano del Garda (Italy) for a two-day meeting hosted by the University of Verona.
Tthe VaMPIRE consortium gathered in Barcelona for a two-day meeting hosted by the project coordinator, Linkcare Health Services, on 23-24th
Oncomatryx, partner and coordinator of the NEXTOM project, visited Leitat’s facilities at the Parc Científic de Barcelona (PCB) for an
The DiMεD project has enabled progress in technologies for surgical implants adapted to each patient through the research of new
Recently, the TEN4CARE consortium gathered in Bilbao for its 6-Month General Assembly. Two intense and highly productive days of co-creation,
Bio-based Polymers for New Sustainable Water-Soluble Sheets Abstract: The BIOWASHEETS project aims to innovate in the fast-moving consumer goods (FMCG)
Preclinical Discovery and Development of New Compounds as HPK1 Inhibitors for Cancer Treatment Abstract: The overall objective of the project